Tetra Radar · FDA Approvals · Decision date

Intellia Therapeutics, Inc.: FDA decision date

Intellia Therapeutics, Inc. (NTLA) · 10 March 2027

Lonvo-z BLA Under Review BLA ACCEPTED BY FDA REGULATORY REVIEW Priority review granted PDUFA GOAL DATE MARCH 10, 2027 SEPTEMBER 3, 2026 FDA COMMUNICATION: “We are not currently planning to hold an advisory committee to discuss this application.” BLA: Biologics License Application; FDA: U.S.

Source: 8-K/A of 13 November 2026

The decision is pending.

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.